Compounds Show Promise in Search for Tuberculosis Antibiotics
To date, efforts to develop new treatments for TB have been unsuccessful, with current treatments having been used for over 50 years
Tuberculosis
Immune Responses to Tuberculosis Mapped Across 3 Species
Detailed genetic road map will guide research into TB treatments, vaccines
New Clinical Guideline for the Treatment and Prevention of Drug-Resistant Tuberculosis
New guideline emphasizes treatment of drug-resistant tuberculosis with all-oral regimens and provides recommendations for treatment of all contacts to MDR-TB patients
Using Aspirin to Fight an Expensive Global Killer Infection
Scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken our immune systems
Pulmonary Tuberculosis Can Be Cured with Shorter Treatment
The new study re-analyzed data from three pivotal TB trials that had failed to show the efficacy of four-month treatments over the standard six-month duration
BD Launches TB Panel for Simultaneous Diagnosis and Drug Resistance Testing
BD MAX™ MDR-TB Panel obtains CE-IVD status in Europe
Latent TB Treatment: Shorter Is Better
Game-changing study on treatment of latent Tuberculosis shows a novel, short therapy is safer and more effective in children and adults than standard therapy
NEJM Publishes Final Results from Phase Two Study Showing Vaccines Can Reduce Rate of Sustained TB Infections
Trial offers hope for new revaccination strategies with Bacille Calmette-Guerin (BCG) against Tuberculosis, the world's leading infectious disease killer